Copyright Reports & Markets. All rights reserved.

Global Biological Hemostatic Material Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Biological Hemostatic Material
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Biological Hemostatic Material Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Collagen
    • 1.3.3 Gelatin
    • 1.3.4 Polysaccharides
    • 1.3.5 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Biological Hemostatic Material Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Other
  • 1.5 Global Biological Hemostatic Material Market Size & Forecast
    • 1.5.1 Global Biological Hemostatic Material Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Biological Hemostatic Material Sales Quantity (2018-2029)
    • 1.5.3 Global Biological Hemostatic Material Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Johnson & Johnson
    • 2.1.1 Johnson & Johnson Details
    • 2.1.2 Johnson & Johnson Major Business
    • 2.1.3 Johnson & Johnson Biological Hemostatic Material Product and Services
    • 2.1.4 Johnson & Johnson Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Johnson & Johnson Recent Developments/Updates
  • 2.2 BD
    • 2.2.1 BD Details
    • 2.2.2 BD Major Business
    • 2.2.3 BD Biological Hemostatic Material Product and Services
    • 2.2.4 BD Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 BD Recent Developments/Updates
  • 2.3 Baxter
    • 2.3.1 Baxter Details
    • 2.3.2 Baxter Major Business
    • 2.3.3 Baxter Biological Hemostatic Material Product and Services
    • 2.3.4 Baxter Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Baxter Recent Developments/Updates
  • 2.4 B.Braun
    • 2.4.1 B.Braun Details
    • 2.4.2 B.Braun Major Business
    • 2.4.3 B.Braun Biological Hemostatic Material Product and Services
    • 2.4.4 B.Braun Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 B.Braun Recent Developments/Updates
  • 2.5 Cura Medical
    • 2.5.1 Cura Medical Details
    • 2.5.2 Cura Medical Major Business
    • 2.5.3 Cura Medical Biological Hemostatic Material Product and Services
    • 2.5.4 Cura Medical Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Cura Medical Recent Developments/Updates
  • 2.6 GELITA MEDICAL
    • 2.6.1 GELITA MEDICAL Details
    • 2.6.2 GELITA MEDICAL Major Business
    • 2.6.3 GELITA MEDICAL Biological Hemostatic Material Product and Services
    • 2.6.4 GELITA MEDICAL Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 GELITA MEDICAL Recent Developments/Updates
  • 2.7 Curasan AG
    • 2.7.1 Curasan AG Details
    • 2.7.2 Curasan AG Major Business
    • 2.7.3 Curasan AG Biological Hemostatic Material Product and Services
    • 2.7.4 Curasan AG Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Curasan AG Recent Developments/Updates
  • 2.8 Meril Life Sciences
    • 2.8.1 Meril Life Sciences Details
    • 2.8.2 Meril Life Sciences Major Business
    • 2.8.3 Meril Life Sciences Biological Hemostatic Material Product and Services
    • 2.8.4 Meril Life Sciences Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Meril Life Sciences Recent Developments/Updates
  • 2.9 Zhonghui Shengxi
    • 2.9.1 Zhonghui Shengxi Details
    • 2.9.2 Zhonghui Shengxi Major Business
    • 2.9.3 Zhonghui Shengxi Biological Hemostatic Material Product and Services
    • 2.9.4 Zhonghui Shengxi Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Zhonghui Shengxi Recent Developments/Updates
  • 2.10 Beijing Datsing Bio-tech
    • 2.10.1 Beijing Datsing Bio-tech Details
    • 2.10.2 Beijing Datsing Bio-tech Major Business
    • 2.10.3 Beijing Datsing Bio-tech Biological Hemostatic Material Product and Services
    • 2.10.4 Beijing Datsing Bio-tech Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Beijing Datsing Bio-tech Recent Developments/Updates
  • 2.11 Guizhou Jin Jiu Biotech
    • 2.11.1 Guizhou Jin Jiu Biotech Details
    • 2.11.2 Guizhou Jin Jiu Biotech Major Business
    • 2.11.3 Guizhou Jin Jiu Biotech Biological Hemostatic Material Product and Services
    • 2.11.4 Guizhou Jin Jiu Biotech Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Guizhou Jin Jiu Biotech Recent Developments/Updates
  • 2.12 Beijing Taikesiman
    • 2.12.1 Beijing Taikesiman Details
    • 2.12.2 Beijing Taikesiman Major Business
    • 2.12.3 Beijing Taikesiman Biological Hemostatic Material Product and Services
    • 2.12.4 Beijing Taikesiman Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Beijing Taikesiman Recent Developments/Updates
  • 2.13 Foryou Medical
    • 2.13.1 Foryou Medical Details
    • 2.13.2 Foryou Medical Major Business
    • 2.13.3 Foryou Medical Biological Hemostatic Material Product and Services
    • 2.13.4 Foryou Medical Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Foryou Medical Recent Developments/Updates
  • 2.14 Saikesaisi Holdings Group
    • 2.14.1 Saikesaisi Holdings Group Details
    • 2.14.2 Saikesaisi Holdings Group Major Business
    • 2.14.3 Saikesaisi Holdings Group Biological Hemostatic Material Product and Services
    • 2.14.4 Saikesaisi Holdings Group Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Saikesaisi Holdings Group Recent Developments/Updates
  • 2.15 Biotemed
    • 2.15.1 Biotemed Details
    • 2.15.2 Biotemed Major Business
    • 2.15.3 Biotemed Biological Hemostatic Material Product and Services
    • 2.15.4 Biotemed Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Biotemed Recent Developments/Updates
  • 2.16 Hangzhou Singclean Medical Products
    • 2.16.1 Hangzhou Singclean Medical Products Details
    • 2.16.2 Hangzhou Singclean Medical Products Major Business
    • 2.16.3 Hangzhou Singclean Medical Products Biological Hemostatic Material Product and Services
    • 2.16.4 Hangzhou Singclean Medical Products Biological Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Hangzhou Singclean Medical Products Recent Developments/Updates

3 Competitive Environment: Biological Hemostatic Material by Manufacturer

  • 3.1 Global Biological Hemostatic Material Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Biological Hemostatic Material Revenue by Manufacturer (2018-2023)
  • 3.3 Global Biological Hemostatic Material Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Biological Hemostatic Material by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Biological Hemostatic Material Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Biological Hemostatic Material Manufacturer Market Share in 2022
  • 3.5 Biological Hemostatic Material Market: Overall Company Footprint Analysis
    • 3.5.1 Biological Hemostatic Material Market: Region Footprint
    • 3.5.2 Biological Hemostatic Material Market: Company Product Type Footprint
    • 3.5.3 Biological Hemostatic Material Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Biological Hemostatic Material Market Size by Region
    • 4.1.1 Global Biological Hemostatic Material Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Biological Hemostatic Material Consumption Value by Region (2018-2029)
    • 4.1.3 Global Biological Hemostatic Material Average Price by Region (2018-2029)
  • 4.2 North America Biological Hemostatic Material Consumption Value (2018-2029)
  • 4.3 Europe Biological Hemostatic Material Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Biological Hemostatic Material Consumption Value (2018-2029)
  • 4.5 South America Biological Hemostatic Material Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Biological Hemostatic Material Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Biological Hemostatic Material Sales Quantity by Type (2018-2029)
  • 5.2 Global Biological Hemostatic Material Consumption Value by Type (2018-2029)
  • 5.3 Global Biological Hemostatic Material Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Biological Hemostatic Material Sales Quantity by Application (2018-2029)
  • 6.2 Global Biological Hemostatic Material Consumption Value by Application (2018-2029)
  • 6.3 Global Biological Hemostatic Material Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Biological Hemostatic Material Sales Quantity by Type (2018-2029)
  • 7.2 North America Biological Hemostatic Material Sales Quantity by Application (2018-2029)
  • 7.3 North America Biological Hemostatic Material Market Size by Country
    • 7.3.1 North America Biological Hemostatic Material Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Biological Hemostatic Material Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Biological Hemostatic Material Sales Quantity by Type (2018-2029)
  • 8.2 Europe Biological Hemostatic Material Sales Quantity by Application (2018-2029)
  • 8.3 Europe Biological Hemostatic Material Market Size by Country
    • 8.3.1 Europe Biological Hemostatic Material Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Biological Hemostatic Material Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Biological Hemostatic Material Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Biological Hemostatic Material Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Biological Hemostatic Material Market Size by Region
    • 9.3.1 Asia-Pacific Biological Hemostatic Material Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Biological Hemostatic Material Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Biological Hemostatic Material Sales Quantity by Type (2018-2029)
  • 10.2 South America Biological Hemostatic Material Sales Quantity by Application (2018-2029)
  • 10.3 South America Biological Hemostatic Material Market Size by Country
    • 10.3.1 South America Biological Hemostatic Material Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Biological Hemostatic Material Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Biological Hemostatic Material Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Biological Hemostatic Material Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Biological Hemostatic Material Market Size by Country
    • 11.3.1 Middle East & Africa Biological Hemostatic Material Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Biological Hemostatic Material Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Biological Hemostatic Material Market Drivers
  • 12.2 Biological Hemostatic Material Market Restraints
  • 12.3 Biological Hemostatic Material Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Biological Hemostatic Material and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Biological Hemostatic Material
  • 13.3 Biological Hemostatic Material Production Process
  • 13.4 Biological Hemostatic Material Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Biological Hemostatic Material Typical Distributors
  • 14.3 Biological Hemostatic Material Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Biological Hemostatic Material market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    Biological hemostatic agents are active agents that work to provide hemostasis by activating clotting factors in the final stages of the coagulation cascade. Thrombin is activated by calcium and as noted previously acts to convert fibrinogen to fibrin, stabilizing the clot.

    This report is a detailed and comprehensive analysis for global Biological Hemostatic Material market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Biological Hemostatic Material market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Biological Hemostatic Material market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Biological Hemostatic Material market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Biological Hemostatic Material market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Biological Hemostatic Material
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Biological Hemostatic Material market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, BD, Baxter, B.Braun and Cura Medical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Biological Hemostatic Material market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Collagen
    Gelatin
    Polysaccharides
    Other
    Market segment by Application
    Hospital
    Clinic
    Other
    Major players covered
    Johnson & Johnson
    BD
    Baxter
    B.Braun
    Cura Medical
    GELITA MEDICAL
    Curasan AG
    Meril Life Sciences
    Zhonghui Shengxi
    Beijing Datsing Bio-tech
    Guizhou Jin Jiu Biotech
    Beijing Taikesiman
    Foryou Medical
    Saikesaisi Holdings Group
    Biotemed
    Hangzhou Singclean Medical Products
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Biological Hemostatic Material product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Biological Hemostatic Material, with price, sales, revenue and global market share of Biological Hemostatic Material from 2018 to 2023.
    Chapter 3, the Biological Hemostatic Material competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Biological Hemostatic Material breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Biological Hemostatic Material market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Biological Hemostatic Material.
    Chapter 14 and 15, to describe Biological Hemostatic Material sales channel, distributors, customers, research findings and conclusion.

    Buy now